NCT01938638View on ClinicalTrials.gov

Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 26, 2013

Primary Completion Date

August 17, 2016

Study Completion Date

September 19, 2016

Conditions
Neoplasms
Interventions
DRUG

BAY1143572

Trial Locations (12)

10002

Taipei

10032

New York

29425

Charleston

48109

Ann Arbor

72703

Fayetteville

119228

Singapore

169610

Singapore

02215

Boston

07601

Hackensack

05505

Seoul

110-744

Seoul

120-752

Seoul

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01938638 - Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter